Severe cutaneous papillomavirus disease after haemopoietic stem-cell transplantation in patients with severe combined immune deficiency caused by common gammac cytokine receptor subunit or JAK-3 deficiency.
about
DOCK8 deficiency impairs CD8 T cell survival and function in humans and miceGenetics of SCIDHuman RHOH deficiency causes T cell defects and susceptibility to EV-HPV infectionsHematopoietic stem cell transplantation for primary immunodeficiency diseaseGene Therapy for X-Linked Severe Combined Immunodeficiency: Where Do We Stand?Local administration of cidofovir for human papilloma virus associated skin lesions in transplant recipients.Loss of Jak2 selectively suppresses DC-mediated innate immune response and protects mice from lethal dose of LPS-induced septic shock.Potential large animal models for gene therapy of human genetic diseases of immune and blood cell systemsRecurrent and Sustained Viral Infections in Primary Immunodeficiencies.Keratinocyte antiviral response to Poly(dA:dT) stimulation and papillomavirus infection in a canine model of X-linked severe combined immunodeficiency.EVER proteins, key elements of the natural anti-human papillomavirus barrier, are regulated upon T-cell activationJak3, severe combined immunodeficiency, and a new class of immunosuppressive drugs.Inherited MST1 deficiency underlies susceptibility to EV-HPV infectionsSevere papillomavirus infection progressing to metastatic squamous cell carcinoma in bone marrow-transplanted X-linked SCID dogsSevere combined immunodeficiency. A model disease for molecular immunology and therapy.Interleukin-7 receptor alpha (IL-7Ralpha) deficiency: cellular and molecular bases. Analysis of clinical, immunological, and molecular features in 16 novel patients.CXCR4 mutations in WHIM syndrome: a misguided immune system?Absence of γ-chain in keratinocytes alters chemokine secretion resulting in reduced immune cell recruitment.Warts and all: human papillomavirus in primary immunodeficiencies.The EVER proteins as a natural barrier against papillomaviruses: a new insight into the pathogenesis of human papillomavirus infections.Hematopoietic cell transplantation for correction of primary immunodeficiencies.Evidence of innate lymphoid cell redundancy in humans.Educational paper. The expanding clinical and immunological spectrum of severe combined immunodeficiency.Primary immunodeficiencies: a decade of shifting paradigms, the current status and the emergence of cutting-edge therapies and diagnostics.Severe cutaneous human papillomavirus infection associated with natural killer cell deficiency following stem cell transplantation for severe combined immunodeficiencyMechanisms of carcinogenesis in human skin against the background of papillomavirus infection.An assessment of transcriptional changes in porcine skin exposed to bromine vapor.Hematopoietic stem cell transplantation for primary immunodeficiency diseases.Long-term persistence of a polyclonal T cell repertoire after gene therapy for X-linked severe combined immunodeficiency.Severe combined immunodeficiencies and related disorders.Topical Cidofovir for Recalcitrant Verrucae in Individuals with Severe Combined Immunodeficiency After Hematopoietic Stem Cell Transplantation.Immunity without innate lymphoid cells.Epidermodysplasia Verruciformis: Inborn Errors of Immunity to Human Beta-Papillomaviruses.
P2860
Q24293628-25860FB2-58C0-4DA6-8101-E55A3E195CACQ27499229-ED38F0CB-A8F7-4BBC-8972-EE3A88193776Q29027555-24E5BBA7-0F58-412A-B310-C920450FEFFCQ29305496-5B76AA0D-D1FD-4476-B3DB-7BD32D501138Q30364488-0642CA7F-2C3D-4067-97BA-58B4BBA859C1Q33273039-D97CCFB6-307D-4462-BD5C-711049197F8EQ33541021-B42C2C99-A84F-4BD0-BAB1-AEFB9013AC01Q33589392-4723290D-BA54-4752-892F-03B753308C3BQ33809611-3E32A24A-0666-477D-86F1-F19D8D5DA879Q33904660-0D248DB5-A6C6-408B-B041-C6C7A9B681E5Q34326712-A1FC3362-D2B4-4616-930F-B8F1DC982794Q34386311-C8146CB0-2BCB-459C-8161-159C258A5765Q34406086-709D2450-1757-46F2-82D0-A488FF99654DQ34716887-7BE6E615-F89D-4328-BC62-2F67A0C4DEC3Q36015021-E595F17E-6880-4221-BC3B-87DF7BBA4F05Q36015024-225B7BC3-86CF-480D-B3D2-7CF93530CB41Q36015049-CCEF4DCB-3DB3-4C70-9366-AF40ABDEC4A4Q36410789-4EDFF8BB-3203-42A9-B914-AD3B3FCB6F50Q36455030-5CCB5525-E823-4179-855E-AA42022860BBQ37232535-CA2C6CFC-F438-4123-903F-05A87618850EQ37251051-26D2ECF7-7F28-4A20-8BD9-9631E4C3E4F6Q37357543-B219E28B-F281-49FF-B897-0A41EC9875D2Q37863509-9E57F286-2D54-4705-8994-E9A82997FC93Q38289442-C5D388DB-D83E-4CBB-AAD1-5568059A118DQ39785521-3D653AC1-1471-4F51-9A35-F750F12D786CQ41725717-187E9691-9BC4-4603-85F6-E96FDAC46E05Q42746551-DF00844B-0CD4-4F44-93D7-532419112285Q44797357-B1364D33-7CB0-4E7D-9921-16C86D2B9A84Q45872713-87FE7CDF-C325-4842-96A3-E968BA068324Q45886049-4A2B86E8-6F62-4A4F-9995-3B5229B1714FQ52845767-5EC62F75-54DA-4B20-8247-22B918DD56A4Q53083114-FDF846D6-ADF2-4240-8D59-4952F525154CQ55346681-35EF864C-8014-436D-BBB1-D4F6ED91E4D9
P2860
Severe cutaneous papillomavirus disease after haemopoietic stem-cell transplantation in patients with severe combined immune deficiency caused by common gammac cytokine receptor subunit or JAK-3 deficiency.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年学术文章
@wuu
2004年学术文章
@zh
2004年学术文章
@zh-cn
2004年学术文章
@zh-hans
2004年学术文章
@zh-my
2004年学术文章
@zh-sg
2004年學術文章
@yue
2004年學術文章
@zh-hant
name
Severe cutaneous papillomaviru ...... r subunit or JAK-3 deficiency.
@en
Severe cutaneous papillomaviru ...... r subunit or JAK-3 deficiency.
@nl
type
label
Severe cutaneous papillomaviru ...... r subunit or JAK-3 deficiency.
@en
Severe cutaneous papillomaviru ...... r subunit or JAK-3 deficiency.
@nl
prefLabel
Severe cutaneous papillomaviru ...... r subunit or JAK-3 deficiency.
@en
Severe cutaneous papillomaviru ...... r subunit or JAK-3 deficiency.
@nl
P2093
P50
P1433
P1476
Severe cutaneous papillomaviru ...... r subunit or JAK-3 deficiency.
@en
P2093
Alain Fischer
Caroline Laffort
Christine Bodemer
Françoise Le Deist
Gérard Orth
Isabelle Radford-Weiss
Michel Favre
Silvia Giliani
Stéphane Blanche
Sylvie Fraitag
P304
P356
10.1016/S0140-6736(04)16457-X
P407
P50
P577
2004-06-01T00:00:00Z